|
Market Closed -
Nasdaq
21:00:00 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 223.59 USD | +1.69% |
|
-2.23% | +27.05% |
| 10-02 | Biogen's experimental lupus drug shows benefit against skin symptoms | RE |
| 10-02 | Biogen Says Litifilimab Shows Efficacy in New 52-Week Phase 2 Data | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
